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Abstract
Interleukin (IL)-1 signaling plays a critical role in intestinal immunology. Here, we report that the major population of
intestinal lamina propria lymphocytes expressing IL-1 receptor 1 (IL-1R1) is the lymphoid tissue inducer (LTi)-like cell, a type
of innate lymphoid cell. These cells are significant producers of IL-22, and this IL-22 production depends on IL-1R1 signaling.
LTi-like cells are required for defense against Salmonella enterica serovar Typhimurium. Moreover, colonic LTi-like cell
numbers depend on the presence of the intestinal microbiota. LTi-like cells require IL-1R1 for production of protective
cytokines and confer protection in infectious colitis, and their cell numbers in the colon depend upon having a microbiome.
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Introduction
The mammalian immune system must respond robustly to
intestinal pathogens without initiating inappropriate immune
reactions against the estimated 10
14 commensal intestinal bacteria
[1,2]. Abnormal host-bacterial interactions can result in inflam-
matory diseases such as inflammatory bowel disease or vulnera-
bility to infection [3,4]. While the host and bacterial factors
involved in these interactions are beginning to be elucidated
[5,6,7,8,9,10], a more complete understanding of the different
molecular and cellular factors involved in maintenance of
intestinal homeostasis is necessary for the development of
additional therapeutic agents targeted against disorders of the
intestinal immune system.
Host-bacterial interactions are not limited to balancing protec-
tion against pathogens with tolerance to commensal bacteria:
commensal bacteria also drive the development of the mammalian
immune system. For example, Bacteroides fragilis, a member of the
normal human microbiome, produces polysaccharide A, which
regulates the systemic murine helper T cell (Th)1-Th2 balance [8]
and induces the development of interleukin (IL)-10-producing
regulatory T cells that protect against murine colitis and
experimental autoimmune encephalomyelitis [9,11]. Murine
segmented filamentous bacterium (SFB) contributes to Th17 cell
maturation [6] by stimulating dendritic cells to drive T cell
differentiation through yet-uncharacterized mechanisms that may
involve adhesion proteins, glycan utilization enzymes, or uptake of
metals such as iron [12,13]. Finally, Clostridium species induce the
development of IL-10-producing regulatory T cells in the murine
colon, which protect against chemically-induced colitis and
suppress systemic immunoglobulin E responses [5].
Innate lymphoid cells (ILCs) are increasingly recognized as
being vital to intestinal homeostasis [14,15]. ILCs are found in
large numbers in the intestine and also play a role in airway
mucosal immunity [16]. ILCs are divided into three groups based
on their cytokine production profiles [14]. Group 1 ILCs produce
Th1 cytokines such as interferon (IFN)-c, but not Th17 cytokines.
The natural killer cell is the prototypic group 1 ILC. Group 2 ILCs
produce Th2 cytokines such as IL-5 and IL-13. The ILCs most
relevant to this paper are group 3 ILCs, which produce IL-22
and/or IL-17 and IFN-c and express retinoic acid-related orphan
receptor (ROR)ct. The best-characterized classes of group 3 ILCs
are ILCs, which are NKp46
+ cells that produce IL-22 and unlike
conventional NK cells do not appear to have direct cytotoxic
effects or produce IFN-c [17], and lymphoid tissue inducer (LTi)
cells [15].
LTi cells–named for their role in the generation of secondary
lymphoid organs–are a critical component of the intestinal
immune system. These cells, which are found in secondary
lymphoid tissues and the intestines, are c-kit
+ cluster of differen-
tiation 127 (CD127)
+ RORct
+ but negative for the lineage (Lin)
markers CD3, CD11b, CD11c, or B220 [18,19]. In secondary
lymphoid tissues, LTi cells induce stromal cell expression of
chemokine ligands that recruit T cells, B cells, and antigen
presenting cells into spatially distinct regions by signaling through
lymphotoxin-a1b2 [20] and help maintain memory CD4
+ T cells
[21]. In the intestines, they drive the formation of Peyer’s patches,
as well as isolated lymphoid follicles in the gut that are important
for secretory immunoglobulin A production, which in turn helps
maintain a localized mucosal response to commensal bacteria
without inducing systemic inflammation [22,23,24]. In addition,
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and dextran sodium sulfate (DSS)-induced colitis [26] by secreting
IL-22 [26,27]. IL-22, in turn, has emerged as a major protective
factor against various infectious and inflammatory diseases
[28,29,30] by enhancing tissue healing, inducing anti-microbial
peptide secretion, and recruiting phagocytes [31,32]. As such, LTi
cells play important roles both in preventing inappropriate
immune responses against commensal bacteria and in defense
against intestinal inflammatory conditions.
The role of the intestinal microbiota on group 3 ILCs remains
controversial. Germ-free (GF) mice are varyingly found to have
increased [19,26] and decreased [17,33] IL-22 production. The
microbiota stimulates intestinal antigen presenting cells to produce
IL-1 [34] and IL-23 [35,36], which enhance ILC activity, but also
induces epithelial cells to produce IL-25, which inhibits IL-22
production [26]. Likewise, GF mice may have either normal [37]
or decreased [22] numbers of ILFs. While some studies have found
that GF mice have fewer small-intestinal group 3 ILCs [17,33],
others have found that numbers are normal in GF mice [19,26].
Importantly, the number of small-intestinal LTi cells is not affected
by the microbiota: both specific pathogen-free (SPF) and GF mice
have similar numbers [19]. We are not aware of previous studies
investigating group 3 ILC numbers in the colon.
One major factor that regulates intestinal immunity is
interleukin IL-1 [38]. Classically, IL-1 is known for enhancing a
generalized immune response that includes proliferation and
survival of naı ¨ve T cells, cytokine production and phagocytosis by
macrophages, antigen presentation by dendritic cells, and recruit-
ment of and oxidative burst by neutrophils [39,40]. More recently,
IL-1 has attracted renewed interest because of its effects on IL-17
and IL-22 secretion by lymphocytes. Dong and colleagues first
demonstrated that IL-1, in synergy with IL-6 and IL-23, is
necessary for both dendritic cell (DC)-mediated maturation of
naı ¨ve T cells to Th17 cells and effector function of mature Th17
cells [41]. IL-1 also induces production of Th17 cytokines by other
cell populations, including IL-17 by NKT cells [42] and IL-22 by
ILCs [43,44]. In the intestine, IL-1 plays an important role in
driving both acute and chronic inflammation [38,45,46,47].
Our laboratory recently demonstrated that IL-1 receptor 1 (IL-
1R1) is important for driving the proinflammatory effects of IL-17-
producing cd T cells in both systemic and mucosal immunity [48].
To further explore the role of IL-1R1, we investigated IL-1R1
expression and function in the intestine. We identified high levels
of IL-1R1 expression on intestinal lamina propria (LP) CD4
+ LTi-
like cells. IL-1R1 signaling to these cells results in enhanced
production of IL-17 and IL-22 in vitro. These LTi-like cells are
important mediators in the innate immune response against an
intestinal pathogen, Salmonella enterica serovar Typhimurium (S.
Typhimurium). Finally, we demonstrate that the number of IL-
1R1
+ LTi-like cells in the colon depends on the intestinal
microbiome. Thus, this work has identified a signaling pathway
in LTi-like cells with potential implications in the pathogenesis of
defense against enteric pathogens and inflammatory bowel disease.
Results
Gut-associated IL-1R1
+ LTi-like Cells are Found Primarily
in the Intestinal Lamina Propria
Previous work in our laboratory demonstrated the importance
of IL-1R1 signaling in the production of IL-17 by cd T cells in
mucosal and systemic immune compartments [48]. We were
interested in extending this work by investigating IL-1R1
expression on T cells in the intestinal immune system. We isolated
lymphocytes from the spleen and several gut-associated compart-
ments of wild-type (WT) mice and analyzed them with
fluorophore-conjugated antibodies against IL-1R1 in conjunction
with antibodies against either CD4 or CD8. Flow cytometric
analysis demonstrated that there are populations of CD4
+ cells in
the small-intestinal and colonic lamina propria (cLP) that express
IL-1R1 (Fig. 1A and 1B). In contrast, virtually no CD8
+ cells
express IL-1R1 in the investigated compartments (Fig. 1A and
1C).
We reasoned that as the IL-1R1
+ population constitutes a
significant proportion of all CD4
+ cells in the small-intestinal and
colonic LPs, and a larger proportion in the LPs than the respective
IEL compartments (Fig. 1B), they could have an important
immunologic role, and began to further characterize them.
Surprisingly, additional flow cytometric analysis utilizing the
gating strategy depicted in Fig. 1D demonstrated that these IL-
1R1
+ CD4
+ cells were CD3
2; ,97% of the cLP CD3
2 CD4
+ cells
were IL-1R1
+ whereas virtually none of the CD3
+ CD4
+ T cells
expressed detectable levels of IL-1R1 (Fig. 1D). This IL-1R1
+
CD4
+ CD3
2 population was present in the cLP of Rag1
2/2 mice
as well and accounted for over 95% of the CD4
+ population in the
colonic (Fig. 1E) and small-intestinal (data not shown) LP. Both
colonic and small-intestinal IL-1R1
+ CD4
+ cells are c-kit
+ CD127
+
RORct
+ but do not express the Lin markers CD3, CD11b,
CD11c, and B220 (Fig. 1F and data not shown); thus, they have
the cell surface phenotype of LTi cells [51]. However, because we
do not explicitly demonstrate lymphoid tissue inducer function, we
refer to this population as ‘‘LTi-like’’ cells. Moreover, since
essentially all Lin
2 CD4
+ cells in the intestinal LP are IL-1R1
+,w e
continued to use the markers Lin
2 CD4
+ to identify intestinal IL-
1R1
+ LTi-like cells.
Colonic LTi-like Cells are Significant Innate Producers of
IL-22
Given previous work demonstrating that LTi cells are a major
source of IL-22 in the small intestine [26], we sought to determine
whether colonic LTi-like cells are also a major producer of IL-22
under both healthy and inflammatory conditions. We induced
colitis using the well-characterized DSS model, which is a
chemical colitis mediated primarily by innate immune cells [30].
Rag1
2/2 mice were used because the adaptive immune system
suppresses the function of LTi-like cells [26] and we were
interested primarily in the contribution of LTi-like cells to innate
immunity. DSS colitis in Rag1
2/2 mice induces colonic LTi-like
cells to produce IL-22: the percentage of LTi-like cells producing
IL-22 increases from ,13% in healthy (control) conditions to
,37% in inflammatory (DSS) conditions (Fig. 2A and 2B). In
addition, colonic LTi-like cells constitute a substantial proportion
of the IL-22-producing cells in the cLP of Rag1
2/2 mice (Fig. 2C
and 2D), both in health and in the setting of colitis. Overall, these
data demonstrate that cLP CD4
+ LTi-like cells are important
innate producers of IL-22 and upregulate IL-22 production in the
setting of intestinal inflammation.
Intestinal LTi-like Cells Require IL-1R1 Signaling for IL-23-
induced Production of IL-17 and IL-22
Having demonstrated that cLP LTi-like cells are major innate
IL-22 producers and that virtually all are IL-1R1
+, we were
interested in whether IL-1R1 signaling is important for LTi-like
cell production of Th17 cytokines, as it is in other cell
populations [41,42,43,48]. After culturing small-intestinal and
cLP cell suspensions (which include LTi-like cells, among other
cell types) isolated from WT or IL-1R1
2/2 mice with either
medium alone (control) or IL-23, a known positive regulator of
LTi-like Cells in Salmonella Infection
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+ CD4
+ Lin
2 LTi-like cells are located predominantly in the intestinal lamina propria. (A) Representative
FACS scatter plots depicting IL-1R1
+ cells as a percentage of total CD4
+ or CD8
+ cells in spleen and gut-associated compartments of WT C57BL/6J
mice. Numbers represent percentage of CD4
+ or CD8
+ cells expressing IL-1R1. (B and C) Bar graph depicting IL-1R1
+ cells as a percentage of total
CD4
+ (B) or CD8
+ (C) cells in spleen and gut-associated compartments of WT C57BL/6J mice. Bar represents median; error bar represents standard
error. Filled bars represent anti-IL-1R1 flurophore-conjugated antibodies; empty bars represent isotype control antibodies. Spl, spleen; MLN,
mesenteric lymph nodes; SI, small intestine; IEL, intraepithelial lymphocytes; LPL, lamina propria lymphocytes. Data collected from three independent
experiments. (D) Gating scheme for IL-1R1
+ CD4
+ cells. SSC, side scatter. FSC, forward scatter. Number is the percent of CD4
+ CD3
2 lymphocytes that
are IL-1R1
+ in WT C57BL/6J mice. (E) Scatter plot depicting IL-1R1
+ CD4
+ cells in Rag1
2/2 C57BL/6J mice. Number is the percent of CD4
+ lymphocytes
that are IL-1R1
+ in Rag1
2/2 mice. Gated on CD4
+ lymphocytes as in (D). (F) FACS histograms demonstrating expression of c-kit, CD127, RORct, and Lin
in WT C57BL/6J mice. Plots are gated on IL-1R1
+ CD4
+ cells. Empty, isotype control; filled, antibody. *, p,0.05; **, p,0.01; NS, not significant.
doi:10.1371/journal.pone.0065405.g001
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LTi-like cells that produced IL-22 and IL-17. As expected, IL-
23-stimulated WT cLP LTi-like cells produced IL-22 in greater
proportions than did unstimulated cells (Fig. 3A). However, IL-
23 did not stimulate IL-1R1
2/2 cLP LTi-like cells to produce
IL-22 in greater proportions than media alone (Fig. 3A). Of
note, unstimulated WT and IL-1R1
2/2 cLP LTi-like cells
produced IL-22 in comparable proportions (Fig. 3A). Qualita-
tively, these findings were similar with IL-17, with IL-1R1 being
required for IL-23 stimulation of IL-17 as well; however, a
smaller proportion of LTi-like cells produced IL-17 than IL-22
(Fig. 3B). Again, the percentages of WT and IL-1R1
2/2 LTi-
like cells producing IL-17 are similar at baseline (Fig. 3B). The
pattern of small-intestinal LTi-like cell production of IL-22 and
IL-17 in WT and IL-1R1
2/2 mice was qualitatively similar to
that of colonic LTi-like cells, in that IL-23 stimulation increased
production of IL-22 and IL-17 in WT but not IL-1R1
2/2 LTi-
like cells (data not shown). Colonic LTi-like cells from Rag1
2/2
mice also increased IL-22 production after IL-23 stimulation
(Fig. 3C). Neither WT nor IL-1R1
2/2 LTi-like cells produce
IFN-c either at baseline or following stimulation with IL-23
(Fig. 3D), which demonstrates that cytokine stimulation by IL-
23 is not nonspecific. Taken together, these data indicate that
intestinal LTi-like cells require IL-1R1 for IL-23 stimulation of
IL-22 and IL-17 but that IL-1R1 is not involved in homeostatic
control of either of these cytokines.
LTi-like Cells are Important for Survival Following S.
Typhimurium Infection
Given that IL-22 is important in protection against S.
Typhimurium [29,52] and IL-1R1
+ CD4
+ LTi-like cells in the
intestinal LP are a significant source of innate IL-22 (Fig. 2), we
hypothesized that these cells play an important role in defense
against S. Typhimurium. To test this hypothesis, we depleted
CD4
+ LTi-like cells in Rag1
2/2 mice using a depleting anti-CD4
antibody, an approach similar to that of previous reports [25]. By
day 0, injection of anti-CD4 antibodies depleted ,90% of colonic
IL-1R1
+ CD4
+ LTi-like cells relative to injection of an isotype
control antibody (Fig. 4A). After orally infection with S.
Typhimurium, the mice injected with an anti-CD4 antibody
demonstrated accelerated weight loss (Fig. 4B) and increased
mortality (Fig. 4C) compared to mice injected with an isotype
control. These results clearly demonstrate that CD4
+ LTi-like cells
are critical for survival following S. Typhimurium infection.
However, it is not clear at which step of disease pathogenesis these
cells are most critical: there were no differences in stool bacterial
load (Fig. 4D), bacterial dissemination to the liver or spleen
(Fig. 4E), or inflammation in the cecum or proximal colon (Fig. 4F).
Intestinal Bacteria Influence the Number of Colonic IL-
1R1
+ LTi-like Cells
The effect of the intestinal microbiome on the development and
function of the intestinal mucosal immune system is becoming
increasingly recognized [49]. Although small-intestinal LTi-like
Figure 2. Colonic LTi-like cells are significant innate producers of IL-22. (A) Representative FACS histogram depicting percentage of CD4
+
LTi-like cells that produce IL-22 under control conditions (left panel) and in DSS colitis (right panel) in Rag1
2/2 C57BL/6J mice. (B) Graph summarizing
percentage of CD4
+ LTi-like cells producing IL-22. (C) Representative scatter plot depicting the phenotype of IL-22-producing lymphocytes under
control conditions (left panel) and in DSS colitis (right panel) in Rag1
2/2 C57BL/6J mice. Gated on IL-22
+ lymphocytes. (D) Graph depicting percentage
of IL-22-producing lymphocytes that are CD4
+ LTi-like cells. All graphs represent three independent experiments. *, p,0.05; NS, not significant. For
box and whisker plots, line represents median, box represents 25
th to 75
th percentile range, and whiskers represent range.
doi:10.1371/journal.pone.0065405.g002
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sought to examine whether the microbiome affects cLP LTi-like
cells. We found that GF mice have a lower absolute number of
cLP IL-1R1
+ CD4
+ LTi-like cells than SPF mice (Fig. 5A),
demonstrating that cLP LTi-like cell numbers depend on host-
bacterial interactions. To investigate whether these interactions
require specific bacteria or merely the presence of any bacteria
(perhaps through general microbe-associated molecular patterns
such as Toll-like receptors), we analyzed mice monocolonized with
B. fragilis or SFB, prototypical Gram-negative and Gram-positive
organisms, respectively, that are known to have significant
immunomodulatory effects on the intestinal immune system
[6,8,9]. Neither organism alone increased the number of cLP
LTi-like cells above that of GF mice (Fig. 5A), revealing that cLP
LTi-like cells depend on specific bacteria other than the two
organisms tested.
To attempt to understand which microbe(s) is required for
generation of cLP LTi-like cells, we treated three groups of SPF
mice with a single antibiotic for ,5 weeks beginning at the time of
weaning. Each antibiotic used targets a different class of bacteria:
vancomycin, neomycin, and metronidazole affect Gram-positive,
Gram-negative, and anaerobic bacteria, respectively. Gram
staining of fecal samples verified depletion of the relevant bacterial
populations for the vancomycin- and neomycin-treated mice (data
not shown). Surprisingly, none of the antibiotic treatments had an
effect on the absolute number of cLP IL-1R1
+ CD4
+ Lin
2 LTi-
like cells (Fig. 5B), suggesting that there is either redundancy
between bacterial classes or that relevant host-bacterial interac-
tions occur prior to weaning. To begin to investigate the latter
possibility, we ‘‘conventionalized’’ germ-free mice at weaning (,3
weeks old) by co-housing them with SPF mice, analyzing the cLP
LTi-like cell population at 6–8 weeks of age. Compared to SPF
mice, conventionalized mice had fewer colonic LTi-like cells
(Fig. 5C). Taken together, these results indicate that the intestinal
microbiota plays an important role in the generation of IL-1R1
+
CD4
+ LTi-like cells and that early bacterial exposure may be
necessary to induce normal numbers of cLP LTi-like cells.
Discussion
We focus in this paper on a subset of cells within the larger
category of group 3 ILCs, namely the CD4
+ LTi-like cells. We
have demonstrated that CD4
+ LTi-like cells nearly universally
express IL-1R1. These cells are important producers of IL-22 in
both healthy and inflammatory conditions, and they require IL-
1R1 for IL-23 stimulation of IL-22 and IL-17, highlighting a
signaling pathway important for the activation of these LTi-like
cells. Likely as a result of this IL-22 production, LTi-like cells
enhance survival following S. Typhimurium infection. Finally, we
Figure 3. IL-1R1 is required for IL-23-stimulated IL-17 and IL-22 production by LTi-like cells in vitro. (A and B) Box and whiskers plot
depicting percent of WT (W) or IL-1R1
2/2 (I) colonic CD4
+ LTi-like cells that produce IL-22 (A) or IL-17 (B). (C) Box and whiskers plot depicting percent
of colonic LTi-like cells isolated from Rag1
2/2 (R) C57BL/6J mice that produce IL-22. (D) Box and whiskers plot depicting percent of WT (W) or IL-1R1
2/
2 (I) colonic CD4
+ LTi-like cells that produce IFN-c. Except in (C), cells were isolated from WT (top panels) or IL-1R1
2/2 C57BL/6J mice (bottom panels).
Cells were stimulated by rIL-23 (23; right panels) or medium (M; left panels). Box and whisker plots representative of at least three independent
experiments. *, p,0.05; NS, not significant. For box and whisker plots, line represents median, box represents 25
th to 75
th percentile range, and
whiskers represent range.
doi:10.1371/journal.pone.0065405.g003
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cLP IL-1R1
+ CD4
+ LTi-like cells.
Group 3 ILCs are a major source of innate IL-22 [26,30,53].
There is not entirely clear whether ILC-produced IL-22 is
constitutive [44] or requires induction [17,33,51]. Previous reports
have demonstrated that IL-1R1 signaling is required for steady-
state IL-22 expression in small-intestinal ILCs and that NKp46
2
RORct
+ ILCs are stimulated by IL-23 to produce IL-22 [44]. We
have extended this work by demonstrating that IL-1R1 is essential
for IL-23-induced IL-22 production by LTi-like cells in the cLP
and found that there is very little steady-state production of IL-22
by cLP LTi-like cells. The mechanism by which IL-1 and IL-23
signaling synergize in ILCs is unclear. In CD4
+ T cells, IL-1R1
signaling enhances RORct expression [44] and thus promotes
Figure 4. Depletion of intestinal LTi-like cells increases susceptibility to S. Typhimurium infection. (A) Scatter plot demonstrating
depletion of colonic IL-1R1
+ CD4
+ Lin
2 LTi-like cells by injection of anti-CD4 antibodies. Number of CD4
+ cells (top) and LTi-like cells (bottom) isolated
from cLP of Rag1
2/2 C57BL/6J mice is indicated. Data shown are representative of three experiments. (B-D) Weights (normalized to starting weight)
(B), survival (C), and fecal burden of S. Typhimurium (D) over time following S. Typhimurium infection in isotype control (square) and anti-CD4 (aCD4;
triangle) antibody-treated mice. (E) CFUs of S. Typhimurium in the liver or spleen at time of death in isotype control- and aCD4-treated mice. (F)
Histological scores for the cecum and proximal colon in isotype control- and aCD4-treated mice. *, p,0.05; **, p,0.01; NS, not significant.
doi:10.1371/journal.pone.0065405.g004
Figure 5. Number of colonic IL-1R1
+ CD4
+ LTi-like cells depends on the gut flora. (A) Number of IL-1R1
+ CD4
+ LTi-like cells in the cLP of
Swiss-Webster mice that were either SPF, GF, monocolonized with B. fragilis (BF), or monocolonized with segmented filamentous bacteria (SFB).
n=8210. (B) Number of IL-1R1
+ CD4
+ LTi-like cells in the cLP of SPF Swiss-Webster mice treated for five weeks with either vancomycin (vanco),
neomycin (neo), or metronidazole (metro). N=8210. (C) Number of IL-1R1
+ CD4
+ LTi-like cells in the cLP of Swiss-Webster mice that were either SPF
or born GF and co-housed at weaning age with SPF mice (GFRSPF). n=425. *, p,0.05; ***, p,0.001; NS, not significant. For box and whisker plots,
line represents median, box represents 25
th to 75
th percentile range, and whiskers represent range.
doi:10.1371/journal.pone.0065405.g005
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though, IL-1 does not appear to promote RORct expression [44].
Research on IL-1 and IL-23 signaling in T cells has identified
several molecules other than RORct involved in their synergy,
including aryl hydrocarbon receptor, nuclear factor-kB, phospha-
tidylinositol 3-kinase, novel protein kinase C, and signal transducer
and activator of transcription 3 [54,55,56]. Additional work is
needed to determine whether any of these pathways are involved
in the IL-1/IL-23 synergy seen with LTi-like cells.
The importance of IL-1 in driving LTi-like cell production of
IL-22 has physiologic significance. IL-1 is an acute phase reactant
that can be produced by innate immune, epithelial, and dying
cells, and as its production does not require antigen presentation it
can be produced rapidly [39]. Interestingly, IL-1 signaling does
not appear to play a major role in inducing IL-22 production
under homeostatic conditions (see Fig. 3A and 3B). Like IL-1, IL-
22 is most important in the early phase of infections [25,57] given
that its primary mechanism of protection is believed to involve
promotion of tissue healing [58] that is important for local
containment of disease as opposed to controlling systemic disease.
Our findings that LTi-like cell-depleted mice died earlier but had a
similar extent of disseminated disease at time of death and that
fecal burden of Salmonella was identical in the presence and
absence of LTi-like cells are consistent with this hypothesis. The
fact that we observed no difference in histological scores of the
cecum and colon may be due, in part, to the time point selected;
we were somewhat constrained in when we could assess histology
given that mice injected with anti-CD4 antibodies died rapidly
from the infection. Presumably, the loss of LTi-like cell-produced
IL-22 led to poor tissue healing and earlier bacterial dissemination
that led to accelerated weight loss and earlier death.
There are some limitations with the Salmonella infection and
LTi-like cell depletion model. Although Salmonella affects the entire
intestine–not just the colon [59]–we focused our investigations on
the colon. Given that small-intestinal and colonic LTi-like cells
had qualitatively similar cytokine production patterns (Fig. 3),
small-intestinal LTi-like cells probably have a similar function in
Salmonella infection as cLP LTi-like cells. While we demonstrated
that colonic LTi-like cells were nearly completely depleted with
anti-CD4 antibodies, we did not specifically assess small-intestinal
LTi-like cells, though we presume that these were similarly
depleted. An additional limitation of this model is that injection of
Rag1
2/2 mice with anti-CD4 antibodies is not specific for
depletion of LTi-like cells and may affect other innate cell
populations, such as DCs. Although phagocytosis of bacteria by
DCs drives Salmonella dissemination [59], CD4
+ DCs constitute a
very minor portion of the entire DC population [60]. Moreover,
this anti-CD4 depletion approach is an accepted method to
investigate the role of LTi-like cells in enteric infections [25].
However, we cannot exclude the possibility that another CD4
+ cell
population was also important for survival following S. Typhimur-
ium infection.
There is controversy about the role of the microbiome in
determining ILC numbers [51]. Eberl and colleagues previously
reported that the number of small-intestinal RORct
+ NKp46
2
LTi cells is not significantly different in GF mice compared to SPF
mice, demonstrating that the microbiota does not impact the
ontogeny of these cells [26]. Cell numbers of a different class of
ILCs, small-intestinal NKp46
+ RORct
+ cells, have been varyingly
reported to be normal [44] or decreased [17,33] in GF mice
compared to SPF mice. At first glance, these findings may appear
to conflict with our conclusion that the microbiota impacts colonic
CD4
+ LTi-like cell numbers (see Fig 5A). However, to our
knowledge, this is the first report comparing colonic LTi-like cell
numbers in GF and SPF mice. It is well known that the microbiota
can have immunomodulatory effects restricted to a particular
anatomical compartment. For example, Clostridium species induce
regulatory T cells in the colon but not in the small intestine [5],
yet-unspecified bacteria downregulate colonic but not ileal natural
killer T cells [10], and intestinal colonization with B. fragilis
increases Th1 cell numbers in the spleen but not in the mesenteric
lymph nodes [61]. The mechanism underlying these compart-
ment-related differences in cell numbers is unclear but may be
related to differences in the specific bacterial microenvironment
[62]. In addition to compartment-related differences, it is
important to emphasize that the population of cells studied in
this paper is a subset of the larger class of RORct
+ NKp46
2 ILCs
[19], and conclusions about the larger group may not apply to this
smaller subset.
Similarly, the exact role of the microbiome in influencing
colonic lymphoid tissue development is not entirely clear.
Mebius and colleagues showed that GF mice have normal
numbers of colonic solitary intestinal lymphoid tissues (SILTs)
[37], which argues against a role of the microbiome in driving
clustering of LTi cells in the colon. However, they found that a
greater proportion of the SILTs in GF mice were immature
[37]. In contrast, Eberl and colleagues reported greatly
decreased number and maturation of colonic SILTs in GF
mice [22]. The reasons for this discrepancy are unclear. Of
note, neither paper reported LTi cell number. Nonetheless,
taken together with these earlier publications, our findings
suggest that the diminished number of the IL-1R1
+ CD4
+ LTi
cells present in GF mice may be sufficient to induce
lymphogenesis under particular circumstances, but that full
maturation of SILTs may either require a greater number of
these cells or additional interactions with the microbiota.
Our attempts to identify a specific class of organism
responsible for colonic LTi-like cell numbers were unrevealing
in that antibiotic treatment of adult mice with three antibiotics
chosen for their specific spectra of activity does not affect LTi-
like cell counts. In addition, bacterial colonization of adult GF
mice does not lead to full restoration of LTi-like cell numbers.
In contrast, Th17 cell numbers can be rapidly and completely
restored in conventionalized adult GF mice [7]. The discrep-
ancy in these observations may be due to increased redundancy
in the populations of bacteria involved in induction of LTi-like
cells than in that of T cells. Alternatively, an intriguing
possibility is that–similar to natural killer T cells [10]–there is
a critical window period after birth in which LTi-like cell
development is bacteria-dependent, after which subsequent
perturbations in the microbiota have little effect on cell
numbers. In this study, the antibiotic-treated mice were raised
under SPF conditions until weaning; moreover, we ‘‘conven-
tionalized’’ GF mice at three weeks of age, which may be
beyond the critical window period. Although our data only
suggest and do not definitively demonstrate that there is such a
window period, one can envision a teleological imperative for
innate immune cells–which constitute the front line of defense
against infection [25]–to be programmed early in life and not
be subject to fluctuations in the microbiota [10]. On the other
hand, cells of the adaptive immune system, which specifically
recognize a greater diversity of antigens, need to be able to
respond to a changing environment; accordingly, these cell
numbers vary dynamically with the microbiota [2,6,7]. Future
studies will further delineate the effect of the timing of microbial
exposure on LTi-like cells and other ILCs, with the aim of
identifying specific bacteria that influence these cell types.
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Mice
WT, IL-1R1
2/2, and Rag1
2/2 C57BL/6J mice were pur-
chased from Jackson Laboratories. SPF Swiss Webster mice were
initially purchased from Taconic Farms and subsequently bred
and maintained and conventional housing. GF Swiss-Webster
mice were initially purchased from Taconic Farms and subse-
quently bred and maintained in sterile isolators at Harvard
Medical School using sterile food, water, and bedding. Swiss-
Webster were used only for experiments involving comparison of
intestinal flora (i.e. Fig. 5). C57BL/6J mice were used for all other
experiments. GF mice were confirmed to be germ-free by weekly
cultures of fecal samples in aerobic and anaerobic environments.
B. fragilis- and SFB-monocolonized Swiss-Webster mice were
generated as previously described [8,49]. All commercially
obtained mice were maintained in our animal facility for at least
one week after arrival before being used for experimentation. All
procedures with animals were performed according to the
Harvard Medical School Office for Research Subject Protection
guidelines and were approved by the Harvard Medical Area
Standing Committee on Animals.
Cell Isolation
Intestinal intraepithelial lymphocytes and lamina propria
lymphocytes were isolated as previously described [50]. Briefly,
mouse intestines were flushed clean of feces, inverted, and stirred
in 3% FBS, 1 mM EDTA, and 0.015% DTT in PBS at 37uC for
30 minutes to extract intraepithelial lymphocytes and epithelial
cells into the solution. The remaining tissue was digested with
20 mL RPMI 1640 containing 5% FBS, 30 mg collagenase
(Gibco), and 10 mg dispase (Gibco). The resulting suspension was
passed through a strainer (100 mm, Fisher Scientific) and lamina
propria lymphocytes were isolated from this suspension using
centrifugation at 300g for 10 minutes.
Flow Cytometry
Cells were resuspended in FACS buffer (PBS containing 10 mM
EDTA, 15 mM sodium azide, and 1% bovine serum albumin). All
antibodies were purchased from Biolegend, except for antibodies
against mouse IL-22, CD3, and CD11c, which were purchased
from BD Biosciences. Cells were labeled with the appropriate
antibodies following manufacturer directions in the presence of
1 mg/mL anti-mouse CD16/CD32 (Biolegend) for 30 minutes at
4uC. Cells were then washed twice, resuspended in FACS buffer,
and analyzed with a FACSCalibur system (BD Biosciences).
Intracellular Staining
Cells were first stained with anti-mouse CD16/CD32 and
fluorophore-conjugated antibodies against surface antigens for 30
minutes at 4uC. The cells were permeabilized and fixed with
Cytofix/Cytoperm solution (100 mL; BD Biosciences) at 4uC
overnight. After two washes with Perm/Wash buffer (BD
Biosciences), cells were labeled with fluorescent-conjugated anti-
bodies against intracellular antigens for 30 minutes at 4uC, washed
twice with a Perm/Wash buffer (BD Biosciences), resuspended in
FACS buffer, and analyzed on a FACSCalibur system (BD
Biosciences).
DSS Colitis
Mice were fed 3% DSS (molecular weight 36,000–50,000; MP
Biomedicals) ab libitum in their drinking water. Weight was
measured daily and mice were euthanized when they lost 20%
of their starting weight or appeared moribund.
In vitro Cytokine Stimulation
Isolated lamina propria lymphocytes were resuspended in PBS
and passed through a column containing approximately 20 mg of
glass wool per colon. These cells were then placed in RPMI 1640
(Invitrogen) containing 10% FBS (Gibco). rIL-23 (Biolegend) or
medium was added as indicated, and the cells were cultured at
37uC with 5% CO2. After 12–16 hours, brefeldin A (Sigma-
Aldrich) was added to a final concentration of 10 ng/mL, and cells
were analyzed by flow cytometry 5 hours later.
Salmonella Studies
Three days and one day prior to infection with S. Typhimurium
(strain SL1433; a kind gift from David Relman), 6–8 week old
mice were injected intraperitoneally with 200 mg anti-CD4
antibody (GK1.5 clone) or isotype control. One day prior to
infection, the mice also received 2 mg streptomycin (Sigma) by
oral gavage. The following day, mice were orally gavaged with
,5610
3 CFU S. Typhimurium. Fecal pellets were collected and
body mass measured daily. Fecal samples were homogenized in
LB broth (Fisher) and plated on LB agar (Fisher); LB broth and
agar contained 200 mg/mL streptomycin (Sigma). Colonies were
counted 16–24 hours later. Cultures of the stool and organs from
uninfected mice did not grow colonies. Mice were euthanized after
losing 20% of their starting weight or when they appeared
moribund. The colon and cecum were harvested for histology at
time of euthanasia. The liver and spleen were also harvested at this
time and homogenized and plated as described above for fecal
samples.
Histopathology
Cecal and proximal colon samples were fixed in Bouin’s
solution (Ricca Chemical Company), and thin sections stained
with hematoxylin and eosin were prepared by the Rodent
Histopathology Core of the Dana Farber/Harvard Cancer
Center. Extent of inflammation was assessed by a pathologist
who had no knowledge of the experimental design. Slides were
scored for inflammation, ulceration, and edema as follows: 0, no
disease; 1, mild disease; 2, moderate disease; 3, severe disease; 4,
very severe disease.
Antibiotic Administration
Vancomycin (0.5 g/L; Sigma-Aldrich), neomycin (1 g/L; MP
Biomedicals), or metronidazole (1 g/L; MP Biomedicals) was
added to the drinking water of mice starting following weaning
(around 3 weeks old). Mice were maintained on the antibiotic until
sacrifice at around 8 weeks of age.
Statistics
In the survival curve in Fig. 4C, statistical significance was
determined using the log-rank test. In Fig. 3, paired t tests were
used. For all other comparisons, statistical significance was
determined using the Mann-Whitney test. For all comparisons, p
values ,0.05 were considered significant.
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